We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study.
- Authors
Shiota, Tetsuya; Murata, Kohei; Kishimoto, Mitsuo; Yao, Takashi; Noura, Shingo; Morita, Shunji; Akiyoshi, Takashi; Okamura, Shu; Imasato, Mitsunobu; Furuhata, Tomohisa; Suto, Takeshi; Takemasa, Ichiro; Shingai, Tatsushi; Ueda, Masami; Mizuno, Hitoshi; Hisamatsu, Yuichi; Takeda, Takashi; Fujii, Makoto; Kagawa, Yoshinori; Sugihara, Kenichi
- Abstract
Purpose: In the 5th edition of the World Health Organization classification, appendiceal goblet cell adenocarcinoma (GCA) is categorized separately from neuroendocrine tumors and other appendiceal adenocarcinomas. We clarified the clinicopathological characteristics of Japanese appendiceal GCA. Methods: We designed a retrospective multicenter cohort study and retrieved the data of patients with appendiceal neoplasms and histologically diagnosed appendiceal goblet cell carcinoid (GCC) treated from January 2000 to December 2017 in Japan. The available GCC slides were reviewed and diagnosed with a new grading system of GCA. Results: A total of 922 patients from 43 institutions were enrolled; of these, 32 cases were patients with GCC (3.5%), and 20 cases were ultimately analyzed. The 5-year survival rate was 61.4% (95% confidence interval: 27.4–83.2), and the median survival time was 93.1 months. For peritoneal metastasis, regional lymph node metastasis was a significant factor (p = 0.04), and Grade 3 was a potential factor (p = 0.07). No peritoneal metastasis was observed in either T1/2 patients (n = 2) or Grade 1 patients (n = 4). We were unable to detect any significant factors associated with regional lymph node metastasis. Conclusion: For peritoneal metastasis, regional lymph node metastasis was a significant factor, and Grade 3 was a potential factor.
- Subjects
JAPAN; WORLD Health Organization; APPENDIX (Anatomy); LYMPHATIC metastasis; CLINICAL pathology; ADENOCARCINOMA; NEUROENDOCRINE tumors; GIANT cell arteritis
- Publication
Surgery Today, 2023, Vol 53, Issue 2, p174
- ISSN
0941-1291
- Publication type
Article
- DOI
10.1007/s00595-022-02562-z